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Abstract
Purpose The aim of this study was to cross-culturally adapt
the PASS-20 questionnaire for use in Libya.
Methods Participants were 71 patients (42 women) attending
the physiotherapy clinic, Ibn Sina Hospital, Sirt, Libya for man-
agement of persistent pain and 137 healthy unpaid undergrad-
uate students (52 women) from the University of Sirt, Libya.
The English PASS-20 was translated into Arabic. Patients com-
pleted the Arabic PASS-20 and the Arabic Pain Rating Scales
on two occasions separated by a 14-day interval. Healthy par-
ticipants completed the Arabic PASS-20 on one occasion.
Results The internal consistency (ICC) for pain patient and
healthy participant samples yielded a good reliability for the
total score, cognitive anxiety, fear of pain, and physiological
anxiety. The test-retest reliability of the Arabic PASS-20 score
showed high reliability for the total score (ICC = 0.93,
p < 0.001), escape/avoidance (ICC = 0.93, p < 0.001), fear of
pain (ICC = 0.94, p < 0.001), and physiological anxiety sub-
scales (ICC = 0.96, p < 0.001) and good reliability for the
cognitive anxiety (ICC = 0.85, p < 0.001). Inspection of the
Promax rotation showed that each factor comprised of five
items were consistent with the theoretical constructs of the
original PASS-20 subscales.
Conclusion The Arabic PASS-20 retained internal consisten-
cy and reliability with the original English version and can be
used to measure pain anxiety symptoms in both pain and
healthy individual samples in Libya.
Keywords Pain . Anxiety . Fear of pain . Psychometric
analysis . Libya
Introduction
Psychosocial factors such as fear of pain, catastrophizing, de-
pression, and anxiety are determinants of differences in pain
responses. Anxiety, a negative emotional response to an an-
ticipated threat, is linked with increased pain sensitivity in
patients with chronic pain [1] and in pain-free individuals
exposed to painful stimuli [2]. Studies on patients with mus-
culoskeletal pain have found that aspects of behaviour such as
fear-avoidance beliefs, pain-related fear, and thought suppres-
sion are associated with pain and disability [1]. Indeed, fear of
pain and fear-avoidance behaviour were developed as a con-
cept to explain exaggerated pain perceptions in patients and
might help in understanding how and why some individuals
with musculoskeletal pain develop a chronic pain syndrome
[3]. Anxiety that is specifically relevant to pain, called pain-
related anxiety, is more likely to be correlated with pain sen-
sitivity than general anxiety [4].
Several measures are used to assess pain-related anxiety.
The multi-dimensional Pain Anxiety Symptom Scale (PASS)
is one of the most commonly used pain-specific anxiety
scales. The PASS is a 40-item self-report scale which was
developed to measure the fear of pain along four dimensions;
fearful interpretations, avoidance and escape, physiological
responses, and cognitive interference [5, 6]. There is strong
empirical evidence that the PASS is associated with pain se-
verity and other measures such as patient functioning [4]. In
addition, several psychometric studies have shown that the
* Osama A. Tashani
O.tashani@LeedsBeckett.ac.uk
1 Centre for Pain Research, Leeds Beckett University, Leeds, UK
2 MENA research group, Leeds Beckett University, Leeds, UK
3 Sirte University, Sirte, Libya
4 Sohag University, Sohag, Egypt
Int.J. Behav. Med.
DOI 10.1007/s12529-016-9608-1
four dimensions (factors) of the PASS are consistently repro-
ducible in patients and healthy participants [6]. McCracken
et al. found that scores from the PASS and the Fear
Avoidance Beliefs Questionnaire (FABQ) Baccounted for
more variability in pain, disability, and pain behaviour com-
pared with scores from the FPQ [Fear of Pain Questionnaire]
and STAI [the State-Trait Anxiety inventory]^ [6]. This sug-
gests that the PASS is a more appropriate tool to measure
multiple anxiety response categories toward pain and is pref-
erable than measuring general response tendencies.
The short form of the PASS is a 20-item self-report scale
that measures four components of fear of pain, including cog-
nitive anxiety, escape and avoidance, fearful appraisals of
pain, and physiological anxiety (PASS-20, Appendix 1, (8)).
Items are rated for frequency of occurrence on a 6-point Likert
scale anchored at 0 (never) and 5 (always), providing scores
for the four dimensions and total. The PASS-20 has been
validated in chronic pain patients [7] and healthy individuals
[8]. Cross-cultural adaptation of the questionnaire to other
languages has been performed in South Korea [9], Germany
[10], and China [11]. To our knowledge, there are no pub-
lished reports of the linguistic validity of the PASS-20 when
administered to Arabic populations. There is a need to develop
an Arabic version of the PASS-20 to facilitate multinational
studies and to compare research results between countries. A
protocol of forward and back translation, cultural adaptation,
and scale validation is required [12].
The aim of this study was to cross-culturally adapt the
PASS-20 questionnaire for use in Libya. The objectives of this
study were to 1) cross-culturally adapt the PASS-20 question-
naire for use in Arabic-speaking populations, 2) test the psy-
chometric properties of the Arabic PASS-20 with the original
English PASS-20, and 3) compare Arabic PASS-20 responses
of pain patients and healthy pain-free participants.
Methods
The study was approved by the medical research ethics com-
mittee at the University of Sirt, Libya and the research ethics
committee at Leeds Beckett University, UK. The protocol for
translating the PASS-20 followed the guidelines for cross-
cultural adaptation of self-report measures [12]. The analysis
of reliability and validity was conducted on the final Arabic
version of the PASS-20.
Phase 1: Translation and Cross-Cultural Adaptation
1. Translation: The PASS-20 was translated from English to
Arabic independently by two bilingual academics who
were fluent to a professional level in English language
and whose mother tongue was Arabic. Permission to un-
dertake the translation was given by the author of the
PASS-20; Lance McCracken, King’s College, London,
United Kingdom.
2. Synthesis of the translation: The two translations of the
PASS-20 were synthesized to develop a consensus version.
3. Back translation: The re-conciliatedArabic versionwas back
translated into the source language by a professional Arabic-
English translator who was blind to the original version.
4. Expert committee review: A psychologist and two aca-
demics not involved in the translation reviewed all trans-
lated versions of the PASS-20 and discussed possible dis-
crepancies. They developed the final version of the Arabic
PASS-20 (Appendix 2).
5. Pre-testing: The translated questionnaire was pretested on
60 healthy individuals who participated in a cold pressor
pain experiment previously described by Tashani et al.
[13].
Phase 2: Psychometric Testing Including Reliability
and Validity of the Arabic PASS-20
Enrolment of Patients and Healthy Participants
Seventy-one patients (42 women, mean age (SD) = 32 [10]
years) with persistent pain who had been referred by their
physicians to the physiotherapy clinic at Ibn Sina Teaching
Hospital, Sirt, Libya took part in the study.Medical notes were
used to confirm that all patients had recurring episodes of pain
of more than 6 months before referral. Twenty-four of these
patients (34%) were diagnosed as having low back pain, 13
(19%) had postoperative or traumatic pain comprised, and 9
(13%) had osteoarthritis or rheumatoid arthritis. The rest of the
patients had neck pain, shoulder pain, lower leg pain, and foot
pain. Only three patients had multiple sources of pain.
One hundred and thirty-seven healthy pain-free unpaid un-
dergraduate students from the University of Sirt, Sirt, Libya
(52 women, mean age (SD) = 21 [2] years) were recruited via
announcements in lectures and noticeboard advertisements.
The healthy participants served as a control group to compare
the PASS-20 scores with pain patients and to test the discrim-
inatory power of the instrument within the two sample popu-
lations. To be eligible for the study, healthy participants had to
have no previous chronic pain complaints.
To test-retest the reliability of the Arabic PASS-20, patients
completed the Arabic PASS-20 and an Arabic Pain Rating
Scale (PRS, available from the British Pain Society website)
on two occasions separated by a 14-day interval. Patients re-
ceived physiotherapy treatment that was tailored to their needs
during this interval. Healthy participants completed the Arabic
PASS-20 on one occasion. Participants in both groups were
instructed to report any words that they found to be unclear.




Patients and healthy participants completed a questionnaire to
document age, sex, marital status, education, financial status,
and course of pain.
Pain Rating Scales
Patients completed pain rating scales to assess 1) present pain
intensity, 2) pain intensity in the last week, 3) distress due to
present pain, 4) distress due to pain during last week, and 5)
pain interference with daily life. Each scale was scored be-
tween 0 (no pain intensity, distress or interference) and 10 (the
worst possible outcome). In addition, patients answered the
question BIf you have had treatment for your pain, how much
has this relieved (taken away) the pain?^ where 0% represent-
ed no relief of pain and 100% represented complete relief of
pain.
Pass-20
The 20-item PASS-20 has four subscales measuring factorial
distinct components of pain-related anxiety. The cognitive
subscale assesses cognitive anxiety symptoms, such as racing
thoughts and impaired concentration due to pain; the fear sub-
scale assesses fearful thoughts and anticipated negative con-
sequences of pain; the escape/avoidance subscale assesses es-
cape and avoidance of actions that may cause pain; and the
physiological anxiety subscale assesses physiological arousal
in response to pain [7]. Respondents rate each item on a six-
point scale ranging from 0 (never) to 5 (always). Total scores
range from 0 representing no pain anxiety to 100 representing
severe pain anxiety.
Data Analysis
Factor analysis was conducted to determine whether the
Arabic version of the PASS-20 had the same number of factors
as the English version. It has been recommended that the
sample size to undertake such an analysis should be approxi-
mately five times the number of items in the instrument [14].
Mean, standard deviation, and 95% confidence interval were
used to express the variability of data, and the Kolmogorov-
Smirnov was test used to check whether data was normally
distributed.
The internal consistency of items in the Arabic PASS-20
was assessed using the Cronbach’s alpha, which indicates the
extent to which a set of test items can be treated asmeasuring a
single latent variable. Item-to-total correlations of the Arabic
PASS-20 were assessed using the Spearman correlation coef-
ficients. Intra-Class Correlation Coefficients (ICC) were used
to test-retest reliability according to the method described by
Bland and Altman [15, 16]. Differences in scores of the
Arabic PASS-20 scores taken on two occasions for patients
were analysed using the paired sample t test.
Exploratory factor analysis was carried out to explore the
dimensionality of the Arabic PASS-20. The Kaiser-Meyer-
Olkin and the Barlett test of sphericity were performed to
determine the sampling adequacy for principle components
analysis (PCA) [14]. A PCAwas then performed to determine
if the four dimensions (subscales) could represent four distinct
variables. Oblique (Promax) rotation was applied to minimize
the complexity of loading for each component. For each item,
acceptable construct validity was defined as loading of 0.3 or
greater on the first principle component with a 0.10 or greater
difference in loadings with the other factors. The scree test and
the eigenvalues (above 1) were used to identify the number of
factors. The factor model was then tested in the two groups
(pain patients and healthy pain-free participants) using a con-
firmatory factor analysis (CFA). A CFAwith maximum like-
lihood was conducted to confirm that the measurement prop-
erties of the original version of the instrument applied to the
Arabic version and to compare the model obtained with the
original factor model of the PASS-20. The fit of the CFA
model was assessed using the chi-squared test where ×2/df
values should be less than 3.0; the Comparative Fit Index
(CFI) where values close to or greater than 0.90 reflect a good
fit to the data; the Root-Mean-Square Error of Approximation
(RMSEA) where values of less than 0.05 indicate a good fit
and values as high as 0.08 represent reasonable errors of ap-
proximation; and the Expected Cross Validation Index (ECVI)
to compare the competing models with lower values indicat-
ing better fit [10].
For pain patients, a series of intraclass correlations were
calculated to examine the correlation between pain rating
scales of the first and second assessments and to examine
the effect sizes of the correlations between the Arabic PASS-
20 total score, subscales, and pain severity. Cohen’s guidelines
were used to categorize the strength of the correlation coeffi-
cient [8]. An independent t test analysis was applied to the
Arabic PASS-20 total score and subscale scores to determine
if there were differences between pain patient and healthy
pain-free participants. Significance level was set at p < 0.05
(two-tailed). Data analyses were performed using the SPSS
and AMOS Version 19.0 (IBM, Ottawa, Canada).
Results
Phase 1: Translation and Cross-Cultural Adaptation
Verbal feedback from pain patients and healthy pain-free par-
ticipants suggested that the Arabic PASS-20 questionnaire
Int.J. Behav. Med.
was easy to understand, and they reported no difficulty in
completing it.
Phase 2: Psychometric Testing Including Reliability
and Validity
The internal consistency for the pain patient and healthy
pain-free samples yielded good reliability for the total
score and for the subscales cognitive anxiety, fear of pain,
and physiological anxiety (Table 1). Low internal consis-
tency was found for the subscale escape/avoidance in both
samples (0.60 and 0.65, respectively). The ICC of the in-
strument was further supported by the item-to-total corre-
lation which fell within the desirable range (0.2 to 0.8).
Item 6, BI try to avoid activities that cause pain,^ was poor-
ly correlated with the total of the remaining items (0.13) in
the healthy sample. An item-total correlation of 0.60 was
found for item 6 in the pain patient sample. The test-retest
reliability showed high reliability and significance for the
total score (ICC = 0.93, p < 0.001) and for the subscales
scape/voidance (ICC = 0.93, p < 0.001), fear of pain
(ICC = 0.94, p < 0.001), and physiological anxiety
(ICC = 0.96, p < 0.001). There was good reliability for
the subscale cognitive anxiety (ICC = 0.85, p < 0.001).
The stability of the instrument was supported by a paired
sample t test that indicated no significant differences in
total and subscale scores over a 14-day period.
Factor Analysis
Table 2 presents the factor solution in the healthy group
(n = 137). The Kaiser-Meyer-Olkin test (KMO) was found
to be 0.75, which exceeds the recommended minimum value
of 0.60 (Kaiser 1974). Barlett’s test of sphericity was highly
Table 1 Internal consistency in the two groups Arabic PASS-20 and test-retest reliability of the questionnaire in patient group only







Cognitive anxiety 0.71 0.78 0.85
I can’t think straight when in pain 0.45 0.54
During painful episodes it is difficult for me to think of
anything besides the pain
0.53 0.54
When I hurt I think about pain constantly 0.35 0.65
I find it hard to concentrate when I hurt 0.40 0.46
I worry when I am in pain 0.34 0.51
Escape Avoidance 0.60 0.65 0.93
I go immediately to bed when I feel severe pain 0.13 0.60
I will stop any activity as soon as I sense pain coming on 0.46 0.46
As soon as pain comes on I take medication to reduce it 0.20 0.54
I avoid important activities when I hurt 0.29 0.44
I try to avoid activities that cause pain 0.31 0.37
Fear of Pain 0.72 0.81 0.94
I think that if my pain gets too severe, it will never decrease 0.27 0.54
When I feel pain I am afraid that something terrible will happen 0.40 0.71
When I feel pain I think that I might be seriously ill 0.40 0.73
Pain sensations are terrifying 0.21 0.65
When pain comes on strong I think that I might become
paralysed or more disabled
0.41 0.60
Physiological Anxiety 0.73 0.70 0.96
I begin trembling when engaged in an activity that increases pain 0.40 0.65
Pain seems to cause my heart to pound or race. 0.35 0.50
When I sense pain I feel dizzy or faint 0.26 0.38
Pain makes me nauseous 0.34 0.52
I find it difficult to calm my body down after periods of pain 0.40 0.63
Total score 0.84 0.88 0.93
*p<0.001
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significant (Barlett’s χ2 (66) = 730.32, p < 0.001) showing that
the data was appropriate for the PCA. Items that loaded 0.3 or
greater on each factor were retained within that factor. Both
the scree test and eigenvalues of 5.11, 1.66, 1.50, and 1.45
indicated a four-factor solution and explained 50.2% of the
total variance. The factors were labelled as follows with the
explained variance in parentheses: 1 cognitive anxiety
(26.60%), 2 fear of pain (7.29%), 3. escape/avoidance
(7.72%), and 4. physiological anxiety (8.58%). Inspection of
the Promax rotation showed that each factor was comprised of
five items which were consistent with the theoretical con-
structs of the original PASS-20 subscales. Additionally, initial
item communalities (h2) were moderate, ranging from 0.39 to
0.66 [17] and at least half of the items of each factor had a
factor loading of 0.60 or greater, which supported the factor
stability of the Arabic PASS-20. However, item 10, BI try to
avoid activities that cause pain,^ showed [17] h2 of 0.17 and a
loading of 0.25, but it was not excluded from the final Arabic
PASS-20. The results of the CFA for the Arabic PASS-20 are
shown in Table 3. The χ2/df, CFI, IFI, RMSA, and ECVI
values indicated a better fit for the healthy group compared
with the pain patients.
Group Differences
The Arabic PASS-20 scores were normally distributed for pain
patient and healthy pain-free groups (Table 4). Differences be-
tween pain patients and healthy participants in the Arabic
PASS-20 total and subscale scores were particularly evident
for the fear of pain subscale, demonstrating that pain patients
reported significantly higher scores than the healthy group
(Mean (SD) = 14.76 (7.29) versus 10.94 (6.04), respectively,
p < 0.001, independent t test).
As expected, significant correlations were found between
the Arabic PASS-20 total score and pain rating scales
Table 2 Factor loadings of the Arabic version of the PASS-20 questionnaire after oblique (Promax) rotation
Item no. Item wording Factor loading
Cognitive Fear Escape/avoidance Physiological h2
1 I can’t think straight when in pain 0.786 0.663
2 During painful episodes it is difficult for me to think of
anything besides the pain
0.701 0.705
3 When I hurt I think about pain constantly 0.640 0.428
4 I find it hard to concentrate when I hurt 0.780 0.609
5 I worry when I am in pain 0.445 0.387
6 I go immediately to bed when I feel severe pain 0.487 0.242
7 I will stop any activity as soon as I sense pain coming on 0.635 0.575
8 As soon as pain comes on I take medication to reduce it 0.523 0.440
9 I avoid important activities when I hurt 0.751 0.553
10 I try to avoid activities that cause pain 0.168
11 I think that if my pain gets too severe, it will never decrease 0.713 0.616
12 When I feel pain I am afraid that something terrible will happen 0.776 0.670
13 When I feel pain I think that I might be seriously ill 0.556 0.482
14 Pain sensations are terrifying 0.563 0.419
15 When pain comes on strong I think that I might become
paralysed or more disabled
0.605 0.566
16 I begin trembling when engaged in an activity that increases pain 0.617 0.516
17 Pain seems to cause my heart to pound or race. 0.539 0.497
18 When I sense pain I feel dizzy or faint 0.659 0.394
19 Pain makes me nauseous 0.612 0.530
20 I find it difficult to calm my body down after periods of pain 0.583 0.576
Percent of variation 26.597 7.290 7.715 8.579
Cumulative variance (%) 26.597 33.887 41.602 50.181
Table 3 Goodness-of-fit indices for the Arabic PASS-20 factor models
Group χ2 df χ2/
df
RMSEA CFI IFI TLI
Healthy (n = 137) 256.79 164 1.57 0.065 0.85 0.85 0.82
Pain patients (n = 71) 278.60 164 1.70 0.1 0.77 0.78 0.73




(Table 5). Specifically, the Arabic PASS-20 total score posi-
tively correlated with present pain intensity (r = 0.32,
p = 0.007), pain intensity in the last week (r = 0.27,
p = 0.024), distress due to present pain (r = 0.31, p = 0.009),
distress due to pain during the last week (r = 0.26, p = 0.030),
and pain interference with daily life (r = 0.36, p = 0.002).
Interestingly, only cognitive anxiety and fear of pain subscales
demonstrated significant correlations ranging between medi-
um to large with pain rating scales. No significant correlations
were found between the Arabic PASS-20 total score or sub-
scales and pain relief.
Discussion
This study found that an Arabic language version of the
PASS-20 completed by a sample of Libyan patients with
chronic pain performed satisfactorily on all the components
of analysis of reliability and linguistic validity. Support for the
reliability of the Arabic PASS-20 was based on internal con-
sistency, item-total correlations, and test-retest reliability.
Internal consistency was found to be good for the total score
and acceptable for the subscales, although the internal consis-
tency of escape/avoidance indicated relatively lower stability
of this subscale.
The Cronbach’s alpha of the escape/avoidance sub-
scale was the lowest out of the four dimensions
(subscale); for the pain patients and the sample of
healthy pain-free university students indicating there is
a discrepancy between the five items in this dimension.
Low internal consistency in escape/avoidance compared
to the total PASS-20 was also found by McCracken and
Dhingra [18] (Cronbach’s α 0.75 vs 0.91) and Abrams
et al. [8] (Cronbach’s α of 0.67 vs 0.91). Further anal-
ysis of our data showed that the escape/avoidance sub-
scale also had the lowest item-total correlations and in-
cluded the only item that did not meet the criterion for
factor loading (item 10, BI try to avoid activities that
cause pain^), possibly reflecting cultural differences in
interpreting some words. A low internal consistency of
the subscale escape/avoidance seems to be a common
finding of studies on European participants [10, 19].
The reliability of the scale in the pain patients and
healthy pain-free participants was further strengthened
through item-total correlation [20]. Test-retest reliability
was well established in the pain patient sample with an
ICC of 0.93 for the total score and from 0.76 to 0.89
for the subscales. The stability of the Arabic PASS-20
was also confirmed by the paired t test that found no
significant differences in scores over a 14-day period.
This finding indicates that the Arabic PASS-20 has an
adequate reliability.
Dimensionality of the Arabic PASS-20 was deter-
mined using an exploratory factor analysis (EFA), and
this confirmed a four-factor structure consistent with
previous studies on in clinical [7, 18] and healthy
pain-free [8] populations from Europe and Canada.
These four factors replicate the factor structure of the
original English PASS-20. The first factor emerging
from the present analysis was physiological anxiety,
followed by fear of pain, cognitive anxiety, and es-
cape/avoidance. The results of the confirmatory factor
analysis (CFA) were supportive of the structures sug-
gested by EFA and comparable to the 4-factor model







Mean (SD) Mean (SD) p value
Cognitive anxiety 16.64 (5.74) 17.75 (5.49) 0.183
Escape/avoidance 14.37 (5.55) 15.48 (6.01) 0.187
Fear of pain 10.85 (6.16) 14.77 (7.29) 0.001
Physiological anxiety 11.02 (6.25) 9.59 (6.38) 0.122
PASS-20 total scores 52.94 (17.80) 57.58 (19.80) 0.090












Present pain intensity 0.39* 0.03 0.34* 0.23 0.32
Pain intensity in the last week 0.34* −0.02 0.29* 0.22 0.27
Distress due to present pain 0.52* 0.02 0.28* 0.17 0.31*
Distress due to pain during last week 0.49* 0.01 0.21 0.13 0.26*
Pain interference with daily life 0.42* 0.14 0.35* 0.22 0.36*
If you have had treatment, how much has this relieved the pain 0.05 0.16 −0.18 −0.07 −0.03
*p > 0.05
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established in the European and Canadian populations
using clinical [7, 19] and healthy samples [8]. Given
the above, the Arabic PASS-20 appears to be compara-
ble with the original English PASS-20.
There were no significant differences between men
and women in the Arabic PASS-20 total scores or for
the subscales cognitive anxiety, escape/avoidance, and
fear of pain. Similar results have previously been report-
ed in samples of chronic pain patients [21] and healthy
pain-free students [8], although there was a significant
difference between men and women in the subscale cog-
nitive anxiety in the study by Keogh et al. [20]. It has
been previously reported that women have higher state
anxiety and trait anxiety than men [22]. When the
Arabic PASS20 was correlated with PRS, stronger asso-
ciations were found with cognitive anxiety.
Chronic pain patients and healthy pain-free students
in our Libyan sample reported higher total and subscale
Arabic PASS-20 scores compared with chronic pain pa-
tients [18] and healthy pain-free students [8] from
Europe, suggesting that Libyans may be more anxious
about pain than Europeans. Libyan pain patients had
higher subscale scores for fear than the healthy pain-
free students, probably because they are not experienc-
ing persistent pain affecting the quality of their life.
There is evidence that ethnicity and culture influence
pain-related anxiety. Weisenberg et al. [2] found that
white Europeans showed a lower level of trait anxiety
measured on STAI compared with Puerto Ricans and
African Americans. Black patients reported higher levels
of pain-related anxiety than White patients, although
there were no differences in physical, psychosocial,
and total disability. In the UK, Watson et al. [6] claimed
that South Asian men reported higher PASS-20 scores
than White British counterparts, although there were no
statistically significant differences between the groups.
The findings from our study suggest that Libyans may
be more likely to generate catastrophic thoughts, such
as fear of dying or being seriously ill and impaired
thinking and concentration, than Europeans. Further
studies investigating ethnic variation in anxiety levels
are required to confirm this premise.
Limitations
There were a number of potential shortcomings in this
study that might restrict the generalizability of the find-
ings. The sample size of the pain patient group was
small. There was a marked difference in the age of
participants in the pain patient sample and the healthy
pain-free sample. Treatment received by pain patients in
the 14-day interval between completing the Arabic
PASS-20 was not documented, although there was no
correlation to the question BIf you have had treatment,
how much has this relieved the pain^ and the total
Arabic PASS-20 score. Thus, any treatment taken within
the 14-day interval is unlikely to have had any impact
on pain-related anxiety. It was not possible to evaluate
the construct validity of the Arabic PASS-20 because
we did not administer other instruments that assess
pain-related anxiety symptoms. The goodness of fit
measures did not represent a good fit possibly because
of the small sample size. This was also reflected by the
fact that the CFA model showed a better fit for the
healthy pain-free participants because of the larger sam-
ple size. We recommend that future studies should eval-
uate the Arabic PASS-20 on large samples of patients
with different conditions and that measures of patient
function should be included in the study design.
Conclusion
The Arabic version of the PASS-20 developed in this study
retained internal consistency and reliability with the original
English PASS-20 and can be used to measure pain-related
anxiety in pain patients and in healthy pain-free individuals
in Libya. We hope that our study catalyses further research on
this topic.
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Appendix 1
The English version of PASS-20
PASS-20 Questionnaire Participant Code:
Please rate the frequency of occurrence of each of the 20
behaviours listed below on a 6-point scale from 0 ‘never’ to
5 ‘always’
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1. I can’t think straight when in pain.
0 1 2 3 4 5
2. During painful episodes it is difficult for me to think of anything besides the pain.
0 1 2 3 4 5
3. When I hurt I think about pain constantly.
0 1 2 3 4 5
4. I find it hard to concentrate when I hurt.
0 1 2 3 4 5
5. I worry when I am in pain.
0 1 2 3 4 5
6. I go immediately to bed when I feel severe pain.
0 1 2 3 4 5
7. I will stop any activity as soon as I sense pain coming on.
0 1 2 3 4 5
8. As soon as pain comes on I take medication to reduce it.
0 1 2 3 4 5
Int.J. Behav. Med.
9. I avoid important activities when I hurt.
0 1 2 3 4 5
10. I try to avoid activities that cause pain.
0 1 2 3 4 5
11. I think that if my pain gets too severe, it will never decrease.
0 1 2 3 4 5
12. When I feel pain I am afraid that something terrible will happen.
0 1 2 3 4 5
13. When I feel pain I think that I might be seriously ill.
0 1 2 3 4 5
14. Pain sensations are terrifying.
0 1 2 3 4 5
15. When pain comes on strong I think that I might become paralysed or more disabled.
0 1 2 3 4 5
16. I begin trembling when engaged in an activity that increases pain.
0 1 2 3 4 5
Int.J. Behav. Med.
17. Pain seems to cause my heart to pound or race.
0 1 2 3 4 5
18. When I sense pain I feel dizzy or faint.
0 1 2 3 4 5
19. Pain makes me nauseous.
0 1 2 3 4 5
20. I find it difficult to calm my body down after periods of pain.
0 1 2 3 4 5
Int.J. Behav. Med.
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